在COVID-19大流行期间治疗炎症性肠病的挑战:一个意见
Jonatan Vukovic1,2, Ivana Jukic1,3, Ante Tonkic1,2
1Department of Gastroenterology and Hepatology, Internal Clinic, Clinical Hospital Centre Split, Spinciceva 1, 21000 Split, Croatia.
Journal of clinical medicine
|December 17, 2024
概括
随着COVID-19大流行,炎症性肠病 (IBD) 治疗变得更加复杂,影响了常规护理和免疫抑制治疗的安全性. 在这个全球卫生危机期间探索管理IBD的策略.
科学领域:
- 胃肠道学和免疫学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 全球范围内,COVID-19大流行严重扰乱了医疗保健系统.
- 炎症性肠道疾病 (IBD),包括克罗恩氏病和性结肠炎,需要持续管理.
- 患有IBD的患者通常需要免疫抑制疗法,这在病毒性流行病期间引起了人们的担忧.
研究的目的:
- 在COVID-19大流行期间探索管理炎症性肠病 (IBD) 的挑战.
- 讨论疫情期间IBD治疗所面临的多方面的障碍.
- 确定和讨论克服这些挑战的潜在策略.
主要方法:
- 这篇文章是对挑战和策略的回顾和讨论.
- 它综合了有关IBD护理中断的信息.
- 它检查了与IBD患者的免疫抑制和COVID-19感染相关的问题.
主要成果:
- 常规IBD护理面临重大干扰.
- 关于免疫抑制药物的安全性的担忧加剧了.
- 管理感染COVID-19的IBD患者提出了独特的复杂性.
结论:
- 随着COVID-19的流行,IBD管理出现了巨大的障碍.
- 应对这些挑战需要在医疗保健和患者监测方面采取适应性策略.
- 持续的研究和合作对于在公共卫生紧急情况下优化IBD护理至关重要.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
111
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
111
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Inflammatory Bowel Disease V: Surgical Management
116
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
116
Chronic Bowel Disorders: Introduction
386
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
386
Inflammatory Bowel Disease II: Crohn's Disease
183
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
183


